Effects of amlodipine and enalapril on platelet function in patiens with mild to moderate hypertension

International Journal of Clinical Pharmacology and Therapeutics

Volumn 37, Issue 7, 1999, Pages 323-331

  Hernandez Hernandez R ^a,c   Armas Padilla, M C ^a   Velasco, M ^b   Carvajal, A R ^a   Armas De Hernandez M J ^a   Guerrero Pajuelo, J ^a   Pacheco, B ^a  

^a UNIVERSIDAD CENTROCCIDENTAL LISANDRO ALVARADO   (Venezuela)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^c Unidad de Terapia Medica   (Venezuela)

Author keywords

Amlodipine; Enalapril; Malondialdehyde; Platelet aggregation

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; AMLODIPINE; ARACHIDONIC ACID; COLLAGEN; ENALAPRIL; MALONALDEHYDE; N ETHYLMALEIMIDE;

ADULT; ARACHIDONIC ACID METABOLISM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; HYPERTENSION; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SITTING; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

AMLODIPINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; DOUBLE-BLIND METHOD; ENALAPRIL; FEMALE; HUMANS; HYPERTENSION; MALE; MALONDIALDEHYDE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS;

EID: 0345517304     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Anderson A, Morgan O, Morgan T 1994 Effectiveness of blood pressure control with once daily administration of enalapril and perindopril. Am J Hypertens 7: 371-373
2. Armas-Hernández MJ, Armas-Padilla MC, Carvajal AR et al 1994 Platelet aggregation and malondialdehyde production in hypertensive and healthy volunteers. Am J Hypertens 7: 91A
3. Bassenge E 1992 Clinical relevance of endothelial-derived relaxing factor (EDRF). Br J Clin Pharmacol 34 (Suppl 1); 375-425
4. Born GVR 1962 Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature (Lond) 194: 927-929
5. Buczynski A, Wachowicz B, Kedziora-Kornatowska K et al 1993 Changes in antioxidant enzymes activities, aggregability and malondialdehyde concentration in blood platelets from patients with coronary heart disease. Atherosclerosis 100: 223-228
6. Carvajal AR, Hernández-Hernández R, Lugo-Vallín N et al 1994 Platelet aggregation and malondialdehyde production induced by amlodipine in hypertensive patients. Am J Hypertens 7: 38A
7. Cocheri S, Fiorentini P 1971 Platelet adhesiveness and aggregation in hypertensive patients. Acta Med Scand 525 (Suppl): 273-275
8. De Graaf JC, Banga JD, Moncada S et al 1990 Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 85: 2284-2290
9. Faulkner JD, McGibney D, Chasseaud LF et al 1986 The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily. Br J Clin Pharmacol 22: 21-25
10. Fleishaman AI, Comberg HU, Hames CG 1976 Platelet function and hypertension in humans. J Med Soc NJ 76: 17
11. Fuster V, Dyken ML, Vokonas PS et al 1883 Aspirin as a therapeutic agent in cardiovascular disease. Circulation 87: 659-675
12. Gomi T, Ikeda T, Yuhara M et al 1988 Plasma beta-thromboglobulin to platelet function 4 ratios as indices of vascular complications in essential hypertension. J Hypertens 6: 389-392
13. Gupta RK, Kjeldsen SE, Motley E et al 1991 Platelet function during antihypertensive treatment with quinapril, a novel angiotensin-converting enzyme inhibitor. J Cardiovasc Pharmacol 17: 13-19
14. Helgeland A, Hagelund CH, Strommen R et al 1986 Enalapril, atenolol and hydrochlorothiazide in mild to moderate hypertension. Lancet 1: 872-875
15. Hernández R, Carvajal AR, Guerrero-Pajuelo J et al 1991 The effect of doxazosin on platelet aggregation in normotensive subject and essential hypertensive patients: an in vitro study. Am Heart J 121: 389-394
16. Hernández-Hernández R, Guerrero-Pajuelo J, Carvajal AR, Armas-Padilla MC, Armas de Hernández MJ, Barragan O, Boada-Bodda JJ 1991 Evidence of an antiplatelet aggregation action of doxazosin in patients with hypertension: an ex-vivo study. Am Heart J 121: 395-401
17. Hernández-Hernández R, Carvajal AR, Armas-Hernández MJ et al 1991 Amlodipine in hypertension: its effects on platelet aggregation and dynamic exercise. J Cardiovasc Pharmacol 17: 25-27
18. Hernández-Hernández R, Armas-Hernández MJ, Carvajal AR et al 1994 Amlodipine and cilazapril on platelet aggregation in patients with hypertension. Am J Hypertens 7: 37A
19. Islim IF, Beevers DG, Bareford D 1992 The effect of antihypertensive drugs on in vivo platelet activity in essential hypertension. J Hypertens 10: 379-383
20. Kjeldsen SE, Gjesdal K, Eide I et al 1983 Increased beta-thromboglobulin in essential hypertension: Interactions between arterial plasma adrenaline, platelet function and blood lipids. Acta Med Scand 213: 369-373
21. Lessem JN, Rucinska E, Vickers FF et al 1985 Long-term enalapril - a new converting enzyme inhibitor - in the treatment of mild to moderate essential hypertension, results of a worldwide multiclinic study. Comparing two ways of analysis data. Clin Exp Hypertens A 7: 1515-1539
22. Makris PE, Tsakiris DA, Papadopoulos A, Ballas A 1985 The ratio MDA : MDA-a as a new index of platelet hyperactivity. Haemostasis 15: 331-336
23. Marcus AJ, Weksler BB, Jaffe EA et al 1980 Synthesis of prostacyclin from platelet derived endoperoxides by cultured human endothelial cells. J Clin Invest 66: 979-986
24. Marcus AJ, Safier LB, Hajjar KA et al 1991 Inhibition of platelet function by an aspirin-insensitive endothelial cells ADPase. Thromboregulation by endothelial cells. J Clin Invest 88: 1690-1696
25. Martorana PA, Linz W, Scholkens BA 1991 Does bradykinin play a role in the cardiac anti-ischaemic effect of ACE inhibitors? Basic Res Cardiol 86: 293-296
26. Metha JL 1985 Influence of calcium-channel blockers on platelet function and arachidonic acid metabolism. Am J Cardiol 55: 158B-164B
27. Metha J, Mehta P 1981 Platelet function in hypertension and the effect of therapy. Am J Cardiol 47: 331-334
28. Mroczek WJ, Burris JF, Allenby KS 1988 A double-blind evaluation of the effect of amlodipine on ambulatory blood pressure in hypertensive patients. J Cardiovasc Pharmacol 12 (Suppl 7): S79-S84
29. Moncada S, Palmer RMJ, Higgs AJ 1990 Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacology 43: 109-142
30. Mulsch S, Busse R 1991 Nitric oxide synthase in native and cultured endothelial cells: calcium/calmodulin and tetrahydrobiopterin are cofactors. J Cardiovasc Pharmacol 17: S52-S56
31. Naito C, Kawamura M, Yamamoto Y 1993 Lipid peroxides as the initiating factor of atheroscleosis. Ann NY Acad Sci 676: 27-45
32. Nyrop M, Zweifler AJ 1988 Platelet aggregation in hypertension and the effects of antihypertensive treatment. J Hypertens 6: 263-269
33. Ross R 1993 The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362: 801-809
34. Omvik P, Thaulow E, Herland OB et al 1993 Doubleblind, parallel, comparative study on quality of life during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicenter study. J Hypertens 11: 103-113
35. Santos MT, Valles J, Marcus AJ et al 1991 Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. J Clin Invest 87: 571-580
36. Smith JB, Ingerman CM, Silver MJ 1976 Malondialdehyde formation as an indicator of prostaglandin production by human platelets. J Lab Clin Med 88: 167-172
37. Steering Committee of the Physicians' Health Study Research Group 1989 Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 321: 129-135
38. The Fifth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure 1993. Arch Intern Med 153: 154-183
39. Velasco M, Urbina A, Silva H et al 1991 A double-blind, parallel, comparative evaluation of amlodipine versus captopril in the monotherapeutics treatment of mild to moderate essential hypertension. J Cardiovasc Pharmacol 17 (Suppl 1): S21-S23
40. Valles J, Santos MT, Marcus MT et al 1993 Downregulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins. J Clin Invest 92: 1357-1365
41. Vlachakis ND, Aledort L 1980 Hypertension and propranolol therapy: effect on blood pressure, plasma catecholamines and platelet aggregation. Am J Cardiol 45: 321-325
42. White GC, Levine SN, Steiner AN 1981 Platelet calcium-dependent proteins. Identification and localisation of the calcium-dependent regulation calmodulin in platelets. Am J Hematol 10: 359-367
43. Wilson J, Orchard MA, Spencer AA et al 1989 Antihypertensive drugs non-specifically reduce "spontaneous" activation of blood platelets. Thromb Haemostas 62: 776-778
44. Zanchetti A, Bond MG, Henning M, Neiss A et al 1998 Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens 16: 949-961
45. Zannad F, Bray-Desboscs L, el-Ghwi R et al 1993 Effects of lisinopril and hydrochrothiazide on platelet function and blood rheology in essential hypertension: a randomly allocated double-blind study. J Hypertens 11: 559-564